Public Health Price Protection Act

[AI summary unavailable — showing source text] Title I: Drug Testing and Evaluation - Provides that the Congress finds and declares: (1) that the Federal Government should assume responsibility for the necessary testing of drugs and determine whether such drugs meet the requirements for approval for commercial distribution; and (2) that drug manufacturers, should bear the expense incurred by the Secretary of Health, Education and Welfare in conducting such tests. Authorizes the Secretary to establish, staff, equip, and maintain a National Drug Testing and Evaluation Center for the purpose of testing and investigating drugs for which approval is required pursuant to this Act. States that the Center shall be operated and maintained as a part of the Food and Drug Administration, subject to the supervision and control of the Secretary. Establishes a Drug Testing Review Panel to settle disputes between the Secretary and the sponsor of a drug as to: (1) the period of time necessary to develop the necessary data; and (2) the procedures used in the testing and investigating. Provides that such a Panel shall be composed of three members, one to be selected by the Secretary, one by the sponsor and the third to be selected by the first tw…